Blue Jet Healthcare Ltd (NSE:BLUEJET) reports a robust EBITDA growth and strategic expansions, despite facing revenue recognition hurdles due to extended transit times.

Having seen Congress spend money to onshore semiconductor production, pharma groups are pushing for similar incentives for ...